Christine Marie Utter - 07 Jan 2022 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Signature
/s/ Avraham S. Adler, attorney-in-fact
Issuer symbol
PTCT
Transactions as of
07 Jan 2022
Net transactions value
-$28,778
Form type
4
Filing time
11 Jan 2022, 15:21:35 UTC
Next filing
20 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale $28,778 -747 -4.4% $38.52 16,253 07 Jan 2022 Direct F1, F2
transaction PTCT Common Stock Award $0 +11,600 +71% $0.000000 27,853 07 Jan 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTCT Stock Option (Right to Buy) Award $0 +43,500 $0.000000 43,500 07 Jan 2022 Common Stock 43,500 $38.10 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,175 RSUs from a January 6, 2021 grant of 8,700 RSUs.
F2 Includes 206 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2021 and 285 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2021.
F3 Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
F4 This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.